⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TYRA News
Tyra Biosciences, Inc. Common Stock
Urothelial Carcinoma Market in the 7MM to 2036: 206,300 Incident Cases in 2025 as ADC-Immunotherapy Combos Reshape Care
globenewswire.com
BMY
PFE
AZN
TYRA
JNJ
IBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
accessnewswire.com
TYRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
prnewswire.com
TYRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
accessnewswire.com
TYRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
globenewswire.com
TYRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
accessnewswire.com
TYRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
accessnewswire.com
TYRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
accessnewswire.com
TYRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
accessnewswire.com
TYRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tyra Biosciences, Inc. - TYRA
prnewswire.com
TYRA